文献速递消化内镜消化道肿瘤与早癌

计算机辅助检测、黏膜暴露装置及其联合应用与标准结肠镜检查对腺瘤检出率的比较:一项随机对照试验

Computer-aided detection, mucosal exposure device, their combination, and standard colonoscopy for adenoma detection: a randomized controlled trial.
PubMed 文献 · Gastrointest Endosc · 2022-10-08

一项前瞻性随机对照试验纳入1245例接受筛查结肠镜检查的受试者,随机分为计算机辅助检测(CADe)组、内镜帽辅助结肠镜(EAC)组、CADe+EAC联合组和标准结肠镜对照组,比较腺瘤检出率(ADR)。结果显示联合组ADR为58.8%,显著高于对照组41.9%;仅联合组进展期腺瘤检出率(AADR)显著高于对照组(13.6% vs 7.7%,P=0.02),单独CADe或EAC虽提高ADR但不增加进展期腺瘤检出。

要点

  • CADe+EAC联合组ADR为58.8%,显著高于标准结肠镜组的41.9%(P<.05)。
  • 仅联合组AADR显著高于对照组(13.6% vs 7.7%,P=0.02)。
  • 单独CADe或EAC可提高ADR,但不增加进展期腺瘤检出。

核心结论

  • CADe+EAC联合应用较标准结肠镜显著提高ADR和AADR,但单独CADe或EAC虽大幅增加腺瘤检出,却不增加进展期腺瘤检出,除非联合使用。

研究设计与样本

  • 前瞻性随机对照试验,纳入1245例接受筛查结肠镜检查的参与者,随机分为CADe组、EAC组、CADe+EAC组和标准结肠镜对照组。

主要发现

  • 对照组、CADe组、EAC组和CADe+EAC组的ADR分别为41.9%、52.2%、54.0%和58.8%。
  • 对照组、CADe组、EAC组和CADe+EAC组的pADR分别为25.2%、33.3%、34.9%和37.0%。
  • 对照组、CADe组、EAC组和CADe+EAC组的AADR分别为7.7%、8.3%、8.3%和13.6%。
  • 对照组、CADe组、EAC组和CADe+EAC组的APC分别为0.76、1.11、1.18和1.31。
  • 各干预组与对照组比较,ADR和pADR均显著增加(所有比较P<.05);AADR仅在CADe+EAC组显著高于对照组(P=0.02);APC调整后发生率比在各干预组均显著高于对照组(所有比较P<.01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Computer-aided detection (CADe) and a mucosal exposure device can improve adenoma detection rate (ADR). Potential benefits of combining the 2 modalities have never been studied. This study aimed to compare ADR differences among CADe alone, endocuff-assisted colonoscopy (EAC) alone, and the combination of CADe and EAC (CADe+EAC) with standard colonoscopy. METHODS: This prospective randomized controlled study included 1245 participants who underwent screening colonoscopy. Participants were randomized to CADe, EAC, CADe+EAC, and standard colonoscopy as a control. The primary outcome was ADR. Secondary outcomes were proximal ADR (pADR), advanced ADR (AADR), and the number of adenomas per colonoscopy (APCs). RESULTS: ADRs from the control, CADe, EAC, and CADe+EAC groups were 41.9%, 52.2%, 54.0%, and 58.8%, respectively; pADRs were 25.2%, 33.3%, 34.9%, and 37.0%, respectively; AADRs were 7.7%, 8.3%, 8.3%, and 13.6%, respectively; and APCs were .76, 1.11, 1.18, and 1.31, respectively. Significant increases in ADR and pADR were observed between the intervention and control groups (P < .05 in all comparisons). The AADR was significantly higher only in the CADe+EAC group than in the control group (P = .02). The adjusted incidence rate ratios of APCs were significantly higher in the intervention groups versus the control group (P < .01 in all comparisons). CONCLUSIONS: CADe+EAC significantly improve ADR and AADR over standard colonoscopy. However, although CADe or EAC alone can substantially increase the detection of adenomas, they do not lead to increased detection of advanced adenomas unless used in combination. (Clinical trial registration number: TCTR20200929003.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Aniwan S, Mekritthikrai K, Kerr SJ, et al. Computer-aided detection, mucosal exposure device, their combination, and standard colonoscopy for adenoma detection: a randomized controlled trial. Gastrointest Endosc. 2022. PMID: 36220382. doi:10.1016/j.gie.2022.09.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。